Rapport Therapeutics (RAPP) Enterprise Value (2023 - 2026)
Rapport Therapeutics (RAPP) reported Enterprise Value of -$875.5 million for Q1 2026, down 1417.14% year-over-year from $66.5 million in Q1 2025, and down 1559.76% quarter-over-quarter from -$52.8 million in Q4 2025.
Rapport Therapeutics (RAPP) Enterprise Value (2023 - 2026) Analysis & Trends
Rapport Therapeutics (RAPP) has 4 years of Enterprise Value data on file, last reported at -$875.5 million in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$875.5 million, down 1417.14% year-over-year; the trailing twelve-month figure through Mar 2026 was -$875.5 million (down 1417.14% YoY), and the FY2025 annual result was -$52.8 million, up 82.72% from the prior year.
- Enterprise Value eased to -$875.5 million in Q1 2026 per RAPP's latest filing, from -$52.8 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$39.4 million in Q3 2024 and troughed at -$875.5 million in Q1 2026.
- A 4-year average of -$218.2 million and a median of -$128.9 million in 2023 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2025 and 2026: Enterprise Value surged 82.72% in 2025, then tumbled 1417.14% in 2026.
- A 4-year view of Enterprise Value shows it stood at -$147.5 million in 2023, then sank by 107.0% to -$305.3 million in 2024, then surged by 82.72% to -$52.8 million in 2025, then sank by 1559.76% to -$875.5 million in 2026.
- Business Quant data shows RAPP's Enterprise Value at -$875.5 million in Q1 2026, -$52.8 million in Q4 2025, and -$251.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -2.77 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | -18.44 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -584.73 Mn |
| 10 | Rapport Therapeutics | 1.66 Bn | 1.66 Bn | - | -875.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -875.53 Mn |
| Dec 31, 2025 | -52.75 Mn |
| Sep 30, 2025 | -251.46 Mn |
| Jun 30, 2025 | -465.78 Mn |
| Mar 31, 2025 | -57.71 Mn |
| Dec 31, 2024 | -305.28 Mn |
| Sep 30, 2024 | -39.42 Mn |
| Jun 30, 2024 | -110.27 Mn |
| Mar 31, 2024 | -74.37 Mn |
| Dec 31, 2023 | -147.48 Mn |
| Sep 30, 2023 | -159.41 Mn |
| Jun 30, 2023 | -79.53 Mn |